| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Jun 24 | SLRN Acelyrin | Director Stock Option Common Stock | Grant | Acquire A | No | No | 4.46 | 92,158 | 411.02 k | 92,158 |
| 14 Feb 24 | NMRA Neumora Therapeutics, Inc. Common Stock | Common Stock | Grant | Acquire A | No | No | 0 | 80,000 | 0.00 | 462,345 |
| 14 Feb 24 | NMRA Neumora Therapeutics, Inc. Common Stock | Stock Option Common Stock | Grant | Acquire A | No | No | 18.07 | 160,000 | 2.89 mm | 160,000 |
| 19 Sep 23 | NMRA Neumora Therapeutics, Inc. Common Stock | Common Stock | Buy | Acquire P | Yes | No | 12.6247 | 15,000 | 189.37 k | 15,000 |
